Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 41 of 41 publications.

Villa K, Vass C, Yarlas A, Ruggles J, Bordone L, Kent C, Mansfield C. Patient preferences for attributes of prophylactic treatment in hereditary angioedema: a discrete-choice experiment. Poster presented at the AAAIO/WAO Joint Conference; February 25, 2025. San Diego, CA. [abstract] J Allergy Clin Immunol. 2025 Feb; 155(2 Suppl):AB228. doi: 10.1016/j.jaci.2024.12.701

Hu M, Shoaibi A, Feng Y, Lloyd PC, Wong HL, Smith ER, Amend KL, Kline A, Beachler DC, Gruber JF, Mitra M, Seeger JD, Harris C, Secora A, Obidi J, Wang J, Song J, McMahill-Walraven CN, Reich C, McEvoy R, Do R, Chillarige Y, Clifford R, Cooper DD, Forshee RA, Anderson SA. Safety of ancestral monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 vaccines in US children aged 6 months to 17 years. JAMA Netw Open. 2024 Apr 1;7(4):e248192. doi: 10.1001/jamanetworkopen.2024.8192

Craig T, Baptist A, Anderson J, Zaragoza-Urdaz R, Burnette A, Kelbel T, Riedl M, Vanegas A, Boyle K, Schultz B, Blair C, Sing K, Fox D, Juethner S. Patient-reported outcomes among patients with hereditary angioedema within underrepresented racial or ethnic groups. Poster presented at the 2024 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting; February 23, 2024. Washington, DC. [abstract] J Allergy Clin Immunol. 2024 Feb; 153(2):AB81.

Dolin P, Kielar D, Shavit A, Koegh K, Rowell J, Edmonds C, Meyers J, Esterberg E, Nham T, Chen S. Comorbidities in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data. Poster presented at the 2024 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting; February 23, 2024. Washington, DC. [abstract] J Allergy Clin Immunol. 2024 Feb; 153(2):AB53.

Dolin P, Kielar D, Shavit A, Keogh K, Rowell J, Edmonds C, Meyers J, Esterberg L, Nham T, Chen S. Healthcare resource utilization and costs in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data. Poster presented at the 2024 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting; February 25, 2024. Washington, DC. [abstract] J Allergy Clin Immunol. 2024 Feb; 153(2):AB206.

Hansford HJ, Cashin AG, Jones MD, Swanson SA, Islam N, Douglas SRG, Rizzo RRN, Devonshire JJ, Williams SA, Dahabreh IJ, Dickerman BA, Egger M, Garcia-Albeniz X, Golub RM, Lodi S, Moreno-Betancur M, Pearson SA, Schneeweiss S, Sterne JAC, Sharp MK, Stuart EA, Hernan MA, Lee H, McAuley JH. Reporting of observational studies explicitly aiming to emulate randomized trials: a systematic review. JAMA Netw Open. 2023 Sep 5;6(9):e2336023. doi: 10.1001/jamanetworkopen.2023.36023

Schneider KL, Bell EJ, Zhou CK, Yang G, Lloyd P, Clarke TC, Wilkinson M, Myers EE, Amend KL, Seeger JD, Chillarige Y, Forshee RA, Shoaibi A, Anderson SA, Wong HL. Use of immunization information systems in ascertainment of COVID-19 vaccinations for claims-based vaccine safety and effectiveness studies. JAMA Netw Open. 2023 May 1;6(5):e2313512. doi: 10.1001/jamanetworkopen.2023.13512.

Armstrong MA, Raine-Bennett T, Reed SD, Gatz J, Getahun D, Schoendorf J, Postlethwaite D, Fassett MJ, Peipert JF, Saltus CW, Merchant M, Alabaster A, Zhou X, Ichikawa L, Shi JM, Chiu VY, Xie F, Hunter S, Wang J, Ritchey ME, Chillemi G, Im TM, Takhar HS, Pisa F, Asiimwe A, Anthony MS. Association of the timing of postpartum intrauterine device insertion and breastfeeding with risks of intrauterine device expulsion. JAMA Netw Open. 2022 Feb 28;5(2):e2148474. doi: 10.1001/jamanetworkopen.2021.48474

Petito LC, Garcia-Albeniz X, Logan RW, Howlader N, Mariotto AB, Dahabreh IJ, Hernan MA. Estimates of overall survival in patients with cancer receiving different treatment regimens: emulating hypothetical target trials in the Surveillance, Epidemiology, and End Results (SEER)–Medicare linked database. JAMA Netw Open. 2020 Mar 2;3(3):e200452. doi: 10.1001/jamanetworkopen.2020.0452

Burte E, Leynaert B, Marcon A, Bousquet J, Benmerad M, Bono R, Carsin AE, de Hoogh K, Forsberg B, Gormand F, Heinrich J, Just J, Nieuwenhuijsen M, Pin I, Stempfelet M, Sunyer J, Villani S, Kunzli N, Siroux V, Jarvis D, Nadif R, Jacquemin B. Long-term air pollution exposure is associated with increased severity of rhinitis in 2 European cohorts. J Allergy Clin Immunol. 2020 Mar;145(3):834-842.e. doi: 10.1016/j.jaci.2019.11.040

Meckley L, Coles T, Williams N, DiBenedetti D, McLeod L. Experience with immunoglobulin treatment among patients with PIDD in the US. Poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting; February 22, 2019. San Francisco, CA. [abstract] J Allergy Clin Immunol. 2019 Feb; 143(2 Supplement):AB112. doi: 10.1016/j.jaci.2018.12.341

Guerra S, Melen E, Sunyer J, Xu CJ, Lavi I, Benet M, Bustamante M, Carsin AE, Dobano C, Guxens M, Tischer C, Vrijheid M, Kull I, Bergstrom A, Kumar A, Soderhall C, Gehring U, Dijkstra D, van der Vlies P, Wickman M, Bousquet J, Postma DS, Anto JM, Koppelman GH. Genetic and epigenetic regulation of YKL-40 in childhood. J Allergy Clin Immunol. 2018 Mar;141(3):1105-14. doi: 10.1016/j.jaci.2017.06.030

Devercelli G, Davis K, Brown M, Hollis K, Hunter S, Long J, Jain G, Banerji A. Burden of hereditary angioedema: findings from a US patient survey. Poster presented at the 2018 AAAAI/WAO Joint Congress; March 3, 2018. Orlando, FL. [abstract] J Allergy Clin Immunol. 2018 Feb; 141(2 Suppl):AB57. doi: 10.1016/j.jaci.2017.12.182

Iribarren C, Rahmaoui A, Long AA, Szefler SJ, Bradley MS, Carrigan G, Eisner MD, Chen H, Omachi TA, Farkouh ME, Rothman KJ. Cardiovascular and cerebrovascular events among patients receiving omalizumab: results from EXCELS, a prospective cohort study of moderate-to-severe asthma. J Allergy Clin Immunol. 2017 May;139(5):1489-1495. doi: 10.1016/j.jaci.2016.07.038.

Iribarren C, Rothman KJ, Bradley MS, Carrigan G, Eisner MD, Chen H. Cardiovascular and cerebrovascular events among patients receiving omalizumab: pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trials. J Allergy Clin Immunol. 2017 May;139(5):1678-80. doi: 10.1016/j.jaci.2016.12.953

White MV, Silvia S, Hollis K, Wooddell M, Goss D, Odom D, Cooney D, Bartsch J, Hogue S. EPIPEN4SCHOOLS® survey combined analysis: prevalence and triggers of anaphylactic events. Poster presented at the 2016 AAAAI Annual Meeting; March 4, 2016. Los Angeles, CA. [abstract] J Allergy Clin Immunol. 2016; 137:AB52.

Bateman ED, Esser D, Chirila C, Fernandez M, Fowler A, Moroni-Zentgraf P, FitzGerald JM. Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: systematic review and network meta-analysis. J Allergy Clin Immunol. 2015 Oct;136(4):914-22. doi: 10.1016/j.jaci.2015.03.023

Wooddell M, Goss DS, Hollis KA, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Hogue SL, White MV. Epinephrine administration for cases of anaphylaxis in a US school setting: results from the EpiPen4Schools survey. Poster presented at the 2015 AAAAI Annual Meeting; February 20, 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015 Feb; 135(2):AB212.

Gascon M, Casas M, Morales E, Valvi D, Ballesteros-Gomez A, Luque N, Rubio S, Monfort N, Ventura R, Martinez D, Sunyer J, Vrijheid M. Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy. J Allergy Clin Immunol. 2015 Feb;135(2):370-8. doi: 10.1016/j.jaci.2014.09.030

White MV, Goss D, Hollis K, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 AAAAI Annual Meeting; February 15, 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015 Feb; 135(Suppl 2):AB212.

Hogue SL, Bennett ME, Goss DS, Hollis KA, Millar K, Silvia S, Siegel P, Wolf RA, Wooddell M, White MV. Occurrence of anaphylaxis by school grade level and staff training: findings from the EpiPen4Schools survey. Poster presented at the 2015 AAAAI Annual Meeting; February 23, 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015; 135(2):AB212.

White MV, Goss DS, Hollis KA, Millar K, Silvia S, Siegel P, Bennett ME, Wolf RA, Wooddell M, Hogue SL. EpiPen4Schools survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 AAAAI Annual Meeting; February 2015. Houston, TX. [abstract] J Allergy Clin Immunol. 2015; 135:AB212.

Myers RA, Himes BE, Gignoux CR, Yang JJ, Gauderman WJ, Rebordosa C. Further replication studies of the eve consortium meta-analysis identifies 2 asthma risk loci in European Americans. J Allergy Clin Immunol. 2012 Dec;130(6):1294-301.

Prazma CM, Prillaman BA, Gern JE, Stempel DA. Seasonal asthma exacerbation and viral association in a pediatric population receiving ICS ± LABA therapy. Poster presented at The 2012 AAAAI Annual Meeting; March 2, 2012. Orlando, FL. [abstract] J Allergy Clin Immunol. 2012 Feb 1; 129(2 Supplement):AB164. doi: 10.1016/j.jaci.2011.12.377

Zock JP, Plana E, Anto JM, Benke G, Blanc PD, Carosso A. Domestic use of hypochlorite bleach, atopic sensitization, and respiratory symptoms in adults. J Allergy Clin Immunol. 2009 Oct;124(4):731-738 e.

Martin BG, Andrews CP, Jacobs R, Mohar D, Toler WT, Prillaman BA, Philpot EE. Once-daily fluticasone furoate nasal spray showed greater improvements in relieving nighttime nasal symptoms and increasing peak nasal inspiratory flow versus oral fexofenadine in subjects with Seasonal Allergic Rhinitis (SAR). Poster presented at the AAAI Annual Meeting; March 14, 2008. Philadelphia, PA. [abstract] J Allergy Clin Immunol. 2008 Feb 1; 121(2 Supplement 1):s54-5. doi: 10.1016/j.jaci.2007.12.220

Andrews CP, Martin BG, Jacobs RL, Toler WT, Prillaman BA, Dalal AA, Philpot EE. Once-daily fluticasone furoate nasal spray showed greater improvement in nocturnal quality of life in subjects with seasonal allergic rhinitis compared with oral fexofenadine. Poster presented at the AAAI Annual Meeting; March 14, 2008. Philadelphia, PA. [abstract] J Allergy Clin Immunol. 2008 Feb 1; 121(2 Suppl 1):s53. doi: 10.1016/j.jaci.2007.12.216

Real FG, Svanes C, Omenaas ER, Anto JM, Plana E, Jarvis D. Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol. 2008 Jan;121(1):72-80.

Real FG, Svanes C, Omenaas ER, Anto JM, Plana E, Janson C. Menstrual irregularity and asthma and lung function. J Allergy Clin Immunol. 2007 Sep;120(3):557-64.

Svanes C, Zock JP, Anto J, Dharmage S, Norback D, Wjst M, Heinrich J, Jarvis D, de Marco R, Plana E. Do asthma and allergy influence subsequent pet keeping? An analysis of childhood and adulthood. J Allergy Clin Immunol. 2006 Sep;118(3):691-8.

Zock JP, Heinrich J, Jarvis D, Verlato G, Norback D, Plana E. Distribution and determinants of house dust mite allergens in Europe: the European community respiratory health survey II. J Allergy Clin Immunol. 2006 Sep;118(3):682-90.

Stauffer J, Yancey S, Baitinger L, Prillaman B, Dorinsky P. Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Poster presented at the AAAAI Annual Meeting; March 3, 2006. Miami Beach, FL. [abstract] J Allergy Clin Immunol. 2006 Feb 1; 117(2 Supplement):S280. doi: 10.1016/j.jaci.2005.12.1159

Sunyer J, Jarvis D, Pekkanen J, Chinn S, Janson C, Leynaert B, Luczynska C, Garcia-Esteban R, Burney P, Anto JM, European Community Respiratory Health Survey Study Group. Geographic variations in the effect of atopy on asthma in the European Community Respiratory Health Study. J Allergy Clin Immunol. 2004 Nov;114(5):1033-9. doi: 10.1016/j.jaci.2004.05.072

Prillaman BA, Kral KM. Multiple analyses, multiple populations, one outcome: lack of effect of fluticasone propionate on prepubescent growth. Poster presented at the AAAAI 60th Anniversary Meeting; March 7, 2003. Denver, CO. [abstract] J Allergy Clin Immunol. 2003 Feb 1; 111(2 Supplement 1):s73. doi: 10.1016/S0091-6749(03)80174-4

Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1108-16. doi: 10.1067/mai.2000.105711.

Wolfe J, Rooklin A, Grady J, Munk ZM, Stevens A, Prillaman B, Duke S, Harding S. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1153-61. doi: 10.1067/mai.2000.107037

Laforce C, Woodring A, Baitinger L, House K, Prillaman B, Shah T. 35 Salmeterol 50mcg/Fluticasone propionate 100mcg diskus combination product demonstrates improvements in lung function regardless of baseline corticosteroid therapy. Poster presented at the AAAAI 56th Annual Meeting; March 3, 2000. [abstract] J Allergy Clin Immunol. 2000 Jan 1; 105(1):PS12. doi: 10.1016/S0091-6749(00)90467-6

Lumry W, Windom H, Mendelson L, Pedinoff A, Prillaman B, Baitinger L, Woodring A, House K, Shah T. The salmeterol/fluticasone propionate (50/250 mcg) dry powder combination Diskus has a faster onset of effect compared with salmeterol or fluticasone propionate in patients with asthma. J Allergy Clin Immunol. 1999 Jan;103(1):S132.

Wolfe J, Bell T, Raphael G, Weinstein S, Baitinger L, Woodring A, Prillaman B, House K, Shah T. Efficacy of the salmeterol/fluticasone propionate dry powder combination product in the Diskus (R): a stratified study in patients on salmeterol alone or inhaled corticosteroids. J Allergy Clin Immunol. 1999 Jan;103(1):S228.

Stricker W, Weinstein S, Chervinsky P, Woodring A, Prillaman B, Shah T. Additive benefits of concurrent Salmeterol and fluticasone propionate therapy in asthma. Poster presented at the AAAI/AAI/CIS joint meeting; February 1997. [abstract] J Allergy Clin Immunol. 1997 Jan; 99(1 Part 2):S319. doi: 10.1016/S0091-6749(97)81066-4

Selner J, Boltansky H, Chervinsky P, Pearlman D, Pedinoff A, Weinstein S, Wolfe J, Stevens A, Prillaman B, Hamedani A, Harding S, Field E. Low dose inhaled fluticasone propionate administered once daily or twice daily via the Diskus is as safe and effective as beclomethasone diproprionate in steroid naïve patients with asthma. Poster presented at the AAAI/AAI/CIS Joint Meeting; February 21, 1997. [abstract] J Allergy Clin Immunol. 1997 Jan; 99(1 Part 2):1319. doi: 10.1016/S0091-6749(97)81066-4